In today’s briefing:
- Fast Fitness Japan Inc (7092 JP): Q1 FY03/26 flash update
- Elecom Co Ltd (6750 JP): Q1 FY03/26 flash update
- Dai Ichi Cutter Kogyo Kk (1716 JP): Full-year FY06/25 flash update
- Ferrotec Corp (6890 JP): Q1 FY03/26 flash update
- KEIWA (4251 JP): 1H FY12/25 flash update
- MarketEnterprise Co Ltd (3135 JP): Full-year FY06/25 flash update
- Mrt Inc/Jp (6034 JP): 1H FY12/25 flash update
- Piala (7044 JP): 1H FY12/25 flash update
- Raqualia Pharma (4579 JP): 1H FY12/25 flash update
- Rezil (176A JP): Full-year FY06/25 flash update
Fast Fitness Japan Inc (7092 JP): Q1 FY03/26 flash update
- Revenue reached JPY4.9bn (+15.9% YoY), with JPY2.9bn from directly operated clubs and JPY1.8bn from franchise revenue.
- Operating profit increased 40.8% YoY to JPY877mn, driven by higher revenue and offsetting increased SG&A expenses.
- Gross profit was JPY2.2bn (+18.9% YoY) with a GPM of 44.8%, and SG&A expenses totaled JPY1.3bn (+7.7% YoY).
Elecom Co Ltd (6750 JP): Q1 FY03/26 flash update
- Sales reached JPY28.6bn, a 3.7% YoY increase, with power supplies and I/O devices showing growth.
- Operating profit increased by 18.8% YoY to JPY3.0bn, driven by higher gross profit despite rising SG&A expenses.
- B2C sales were JPY19.4bn (+3.2% YoY), while B2B sales amounted to JPY9.2bn (+5.0% YoY).
Dai Ichi Cutter Kogyo Kk (1716 JP): Full-year FY06/25 flash update
- Full-year FY06/25 revenue declined 3.3% YoY due to decreased construction volume and exclusion of a subsidiary.
- FY06/26 forecast: Revenue JPY20.5bn (+1.3% YoY), Operating profit JPY1.8bn (+9.3% YoY), Net income JPY1.3bn (-2.8% YoY).
- Dai-Ichi Cutter’s profit projections are conservative; profitability depends on project difficulty, scale, and demand response investment.
Ferrotec Corp (6890 JP): Q1 FY03/26 flash update
- Q1 FY03/26 sales increased by 12.7% YoY to JPY68.9bn, while operating profit decreased by 4.9% YoY to JPY6.7bn.
- Semiconductor Equipment-related segment sales rose 3.6% YoY, but segment profit declined 31.5% YoY due to lower quartz crucible sales.
- Automotive-related segment sales grew 53.5% YoY to JPY9.0bn, with segment operating profit increasing 79.2% YoY to JPY1.3bn.
KEIWA (4251 JP): 1H FY12/25 flash update
- Revenue increased by 2.8% YoY to JPY9.9bn, driven by higher sales of optical products for laptops and tablets.
- Operating profit rose 8.9% YoY to JPY2.2bn, aided by improved profitability and segment repositioning efforts.
- Recurring profit decreased 23.6% YoY to JPY2.0bn, while net income attributable to owners dropped 56.0% YoY to JPY694mn.
MarketEnterprise Co Ltd (3135 JP): Full-year FY06/25 flash update
- Revenue reached JPY24.8bn (+30.3% YoY), with significant growth in Second-hand Online and Mobile & Telecommunications segments.
- Operating profit increased to JPY626mn (+109.4% YoY), driven by a 0.9pp rise in the operating profit margin.
- The company forecasts JPY30.0bn revenue (+21.1% YoY) and JPY1.1bn operating profit (+75.8% YoY) for FY06/25.
Mrt Inc/Jp (6034 JP): 1H FY12/25 flash update
- In Q1 FY12/23, revenue was JPY2.3bn (+4.8% YoY), operating profit JPY132mn (+37.6% YoY), pre-tax profit JPY128mn (+47.0% YoY).
- 1H revenue reached 51.7% of FY12/25 forecast, with operating profit at 88.0% and recurring profit at 85.0%.
- Revenue from Medical Personnel Placement Services was JPY1.7bn (+2.2% YoY), Other Services revenue totaled JPY646mn (+12.3% YoY).
Piala (7044 JP): 1H FY12/25 flash update
- Revenue reached JPY8.3bn, a 40.6% YoY increase, with 50% progress against the revised FY12/25 forecast.
- Operating profit was JPY39mn, surpassing the initial forecast, with recurring profit and net income revised upward.
- FY12/25 revenue forecast increased to JPY16.7bn; recurring profit and net income forecasts revised upward by 30.1%.
Raqualia Pharma (4579 JP): 1H FY12/25 flash update
- Operating revenue increased to JPY1.5bn (+8.9% YoY), with a net loss of JPY355mn and R&D expenses at JPY782mn.
- Royalty income from four launched products, including tegoprazan, totaled JPY1.1bn (+7.5% YoY), contributing to operating revenue.
- HK inno.N’s tegoprazan sales in South Korea reached KRW104.7bn (+14.3% YoY), with global expansion in 54 countries.
Rezil (176A JP): Full-year FY06/25 flash update
- FY06/23 revenue was JPY46.6bn (+20.5% YoY); EBITDA was JPY4.4bn (+17.6% YoY); operating profit was JPY3.2bn (+15.1% YoY).
- FY06/25 revenue forecast is JPY57.3bn (+22.9% YoY); operating profit forecast is JPY3.8bn (+18.8% YoY).
- Rezil Inc. supports Bain Capital’s tender offer; shares are scheduled for delisting; dividend forecast undecided.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
